Medical Therapy In Peripheral Artery Disease Using Pentoxifylline

Abstract

In addition to its anti-inflammatory properties, pentoxifylline is an active methyl-xanthine derivative with many other advantages. Many dermatological and non-dermatological diseases respond well to pentoxifylline, which has been studied extensively. A safe and cost-effective alternative to the standard medication, it has been utilised both as a main and adjuvant treatment. Pentoxifylline is discussed in this article as a review of the literature, with an emphasis on different critical elements. A thorough history and physical examination are critical in the diagnosis of PAD, but they are hampered by a lack of consistency in their sensitivity and specificity. You may quickly confirm your diagnosis and stratify your risk with noninvasive office-based diagnostics such as an ankle-brachial index. To evaluate disease progression and forecast cardiovascular and cerebrovascular mortality, the ankle-brachial index is useful. It has a strong correlation with disease severity and functional symptoms and may be utilised to do so. Following a diagnosis of PAD, treatment focuses on risk factor reduction, symptom alleviation, and secondary prevention using antiplatelet medications.